Juli Plc half-year revenue drops 45%

Nigerian pharmaceutical and healthcare retail firm, Juli Plc, recorded a net loss of N12.86m for the half-year period ended 30 June 2026, as top-line performance suffered a sharp contraction. According to the company’s second-quarter financial statements filed with the Nigerian Exchange Limited, half-year turnover plummeted 45.5 per cent to N146.86m, from the N269.25m reported during the corresponding six-month period of 2025. Although the overall half-year net deficit narrowed from the N31.54m loss recorded in the previous year, due to reduced administrative overheads, the drastic drop in total sales underscores ongoing revenue generation challenges across its core operations. The company, founded by Prince Julius Adelusi-Adeluyi, holds a historic position in the Nigerian capital market as the first indigenous company promoted by a Nigerian to be quoted on the Alternative Securities Market of the Nigerian Exchange.